Treatment-resistant advanced non-small cell lung cancer responds to rociletinib

… in patients with non-small cell lung cancer (NSCLC), but also a form … targeted therapies for mutant EGFR lung cancer patients who develop the T790M … say: "Eventually, almost all lung cancer patients with EGFR mutations will …